Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | THIRD HARMONIC BIO INC THRD | RA CAPITAL MANAGEMENT L.P. | 534,687 1.300% | -2,941,000 (-84.62%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 2,249,421 9.900% | 762,950 (+51.33%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | RA CAPITAL MANAGEMENT L.P. | 5,199,746 9.990% | 1,689,643 (+48.14%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | GH RESH PLC SHS GHRS | RA CAPITAL MANAGEMENT L.P. | 4,898,373 9.400% | 2,054,616 (+72.25%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | KINNATE BIOPHARMA INC KNTE | RA CAPITAL MANAGEMENT L.P. | 4,264,144 9.700% | 671,092 (+18.68%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,516,067 9.800% | 645,000 (+13.24%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IMMUNOGEN INC IMGN | RA CAPITAL MANAGEMENT L.P. | 22,075,158 9.990% | -87,800 (-0.40%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | 5:01 ACQUISITION CORP FVAM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PARDES BIOSCIENCES INC PRDS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,431,901 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | SYNLOGIC INC SYBX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -444,444 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ADICET BIO INC ACET | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -147,772 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | MAGENTA THERAPEUTICS INC MGTA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,588,081 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ENTERA BIO LTD SHS ENTX | RA CAPITAL MANAGEMENT L.P. | 295,966 1.000% | -2,057,034 (-87.42%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IO BIOTECH INC IOBTQ | RA CAPITAL MANAGEMENT L.P. | 1,127,260 3.900% | -730,495 (-39.32%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | INSTIL BIO INC TIL | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -383,540 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 7,691,990 9.990% | -41,086,182 (-84.23%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA CAPITAL MANAGEMENT L.P. | 7,040,622 9.600% | 2,075,034 (+41.79%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.200% | -1,629,747 (-29.03%) | Filing History |